News Stories

Baldassarre Stea, MD, PhD, FASTRO

University of Arizona Cancer Center physicians are on the cutting edge of developing safer, more targeted therapies for breast cancer patients undergoing radiation therapy for their disease.

M. Peter Lance, MD, FRCP

M. Peter Lance, MD, FRCP, Professor of Medicine, Molecular and Cellular Biology and Public Health at UA, and the UACC’s Chief Cancer Prevention and Control Officer, has been named Interim Deputy Director for the University of Arizona Cancer Center at St. Joseph’s Hospital and Medical Center/Dignity Health project.

University of Arizona College of Nursing Professor and UA Cancer Center member Terry Badger, PhD, PMHCNS-BC, RN, FAAN, has been inducted into the inaugural class of American Psychosocial Oncology Society (APOS) fellows. 

The UACC's Skin Cancer Institute will provide four sunscreen stations around the UA Mall during this weekend's Tucson Festival of Books. Look for the red topper to guide you to sun-safe bliss.

Becker's Hospital Review has included The University of Arizona Cancer Center and its patient-care affliate, University of Arizona Medical Center, among its "100 Hospitals and Health Systems with Great Oncology Programs."

Samantha Kendrick, PhD

University of Arizona Cancer Center researcher Samantha Kendrick, PhD, was awarded a 2013 Lymphoma Research Foundation Postdoctoral Fellowship award to support her research of non-Hodgkin lymphoma (NHL).

Rendering: ZGF Architects LLP

Ground was officially broken on the new University of Arizona Cancer Center (UACC) at St. Joseph’s Hospital and Medical Center/Dignity Health outpatient facility in downtown Phoenix.

Karen Weihs, MD

Cancer is a disease that attacks more than just a patient’s cells. It often wreaks havoc on an individual’s emotional equilibrium, as well. Karen Weihs, MD, is among the researchers attempting to identify patients who exhibit depressive symptoms in order to help them successfully fight cancer on every level — physically and emotionally.

John Farley, MD

Researchers at The University of Arizona Cancer Center at St. Joseph’s Hospital and Medical Center in Phoenix have discovered that many women with low-grade serous carcinoma of the ovary or peritoneum have seen their tumors stabilize or shrink after taking a regular dose of the compound selumetinib.

University of Arizona Cancer Center clinicians and researchers will present at the Lymphoma Research Foundation's annual patient education and networking forum in Scottsdale March 9.